Blai Coll
Equibles does not estimate personal net worth.
Get an email with a short summary when Structure Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get GPCR alertsAbout Blai Coll
The proxy statement of Structure Therapeutics Inc. reports total compensation of $3,246,947 for Blai Coll in fiscal 2025, including a base salary of $492,813. Disclosed compensation is on record for 2 fiscal years. Structure Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Structure Therapeutics Inc. includes Raymond Stevens (CEO and Board Member), Jun Yoon (CFO), Matthew Lang (COO and General Counsel) and 3 others.
Affiliation history
-
Structure Therapeutics Inc. (GPCR)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2026
Company network
Leadership on record at Structure Therapeutics Inc.
- Raymond Stevens CEO, Board Member
- Jun Yoon CFO
- Matthew Lang COO, General Counsel
- Yingli Ma CTO
- Angus Russell Board Member
- Ted Love, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Structure Therapeutics Inc. (GPCR) | M.D., Ph.D. Chief Medical Officer | $492,813 | $3,246,947 |
| 2024 | Structure Therapeutics Inc. (GPCR) | M.D., Ph.D. Chief Medical Officer | $449,138 | $3,451,040 |
Recent activity
No call appearances or filed executive changes recorded yet.